Top searches

PL

Resources

B2RLaw advises biotech company Ambulero on fundraising

27/01/2021

B2RLaw has advised Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease on funding of up to USD 5.5 million received from from Orphinic Scientific.

As part of the investment, and with the help of B2RLaw, Ambulero and Orphinic formed a Polish subsidiary (Ambulero Sp. z o.o.) that will lead clinical testing of a novel gene therapy for a serious vascular disease in Europe. The disease is rare in the US but more common in certain parts of Central and Eastern Europe.

Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. The company is a 2019 spin-out of the University of Miami co-founded by Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez and Jun Zhao-Liu. It holds an exclusive license from the University of Miami to develop and commercialize research from the laboratories of Drs. Omaida C. Velazquez and Jun Zhao-Liu.

With offices in Palo Alto, California and Warsaw, Poland, Orphinic Scientific is an innovative drug development and investment company focused on mid-market opportunities and orphan drugs in late preclinical research and Phase 1 or 2.

B2RLaw’s team was led by Partner Szymon Syp and included Senior Associate Iga Wojtczak – Opala and Junior Associate Jakub Niemiec.

Szymon Syp advises, “We congratulate Ambulero and Orphinic Scientific on this transaction. Ambulero’s important work means that people that suffer from serious vascular disease (which at best, causes severe discomfort and at worst, can result in death) can live in comfort with the knowledge that innovative treatment is on the horizon. We wish Ambulero the best of luck on its future clinical testing”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

17/04/2025

Happy Easter from B2RLaw!

As Easter approaches, we wish you: + a rest without litigation deadlines, + maybe… a small settlement with calories, + […]

MORE
24/04/2025

Aleksandra Zielińska joins Women’s White Collar Defense Association

Aleksandra Zielińska (Advocate, Associate) has just become a member of Women’s White Collar Defense Association (WWCDA). The WWCDA is a […]

MORE
08/04/2025

B2RLaw at IX UW MOOT 2025

From 8 to 11 April 2025, Wydział Prawa i Administracji Uniwersytetu Warszawskiego (WPiA UW) will host the 9th edition of […]

MORE
27/03/2025

B2RLaw recommended in the Legal 500 EMEA ranking 2025

This year we made it to the prestigious Top Tier 1 White-collar crime in Poland! Other distinguished practices: Construction, Private […]

MORE
25/03/2025

B2RLaw in Chambers & Partners Europe 2025 ranking!

B2RLaw has been recognized by Chambers and Partners Europe 2025! Bartłomiej Jankowski – Band 2 Lawyer in White-Collar Crime & Corporate Investigations […]

MORE
27/02/2025

B2RLaw in Chambers & Partners Global 2025 ranking!

B2RLaw has been recognized by Chambers and Partners Global 2025 in the category Corporate/M&A: Mid-Market! This is the success of the entire corporate […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close